Funder
Fundação de Apoio à Pesquisa do Distrito Federal
Publisher
Springer Science and Business Media LLC
Reference64 articles.
1. Cosimi AB, Urton B, Colvin RB, Goldstein G, Laquaglia MP, Tolkoff-Rubin N, et al. Treatment of acute renal allograft rejection with OKT3 monoclonal antibody. Transplantation. 1981;32(6):535–9.
2. Reichert JM. Marketed therapeutic antibodies compendium. MAbs. 2012;4(3):413–5.
3. Chatenoud L, Primo J, Bach JF. CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. J Immunol. 1997;158(6):2947–54.
4. Chatenoud L, Bluestone JA. CD3-specific antibodies: a portal to the treatment of autoimmunity. Nat Rev Immunol. 2007;7(8):622–32.
5. Utset TO, Auger JA, Peace D, Zivin RA, Xu D, Jolliffe L, et al. Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial. J Rheumatol. 2002;29(9):1907–13.